Viemed Healthcare Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	286.57	270.28	224.26	183.01	138.83	117.06
Revenue Growth (YoY)	23.10%	20.52%	22.54%	31.82%	18.60%	-10.85%
Cost of Revenue	121.56	114.82	91.05	70.23	54.15	43.65
Gross Profit	165.01	155.46	133.2	112.78	84.68	73.41
Selling, General & Admin	137.01	130.5	112.48	93.73	73.36	60.04
Depreciation & Amortization Expenses	1.53	1.49	1.48	1.39	1.01	0.85
Research & Development	2.8	3.02	3.07	2.78	2.7	2.11
Other Operating Expenses	0.27	-2.49	-1.73	0.55	-0.64	-1.17
Total Operating Expenses	141.6	132.51	115.3	98.45	76.43	61.83
Operating Income	23.4	22.95	17.9	14.33	8.25	11.58
Interest Income	-	-	-0.95	0.49	0.94	1.24
Interest Expense	0.7	1.18	0.78	0.42	0.2	0.32
Total Non-Operating Income (Expense)	0.7	1.18	-0.18	0.91	1.13	1.56
Pretax Income	22.1	21.77	16.17	14.39	8.99	12.5
Provision for Income Taxes	6.72	6.39	4.76	4.15	2.77	3.38
Net Income	15.38	15.38	11.41	10.24	6.22	9.13
Minority Interest in Earnings	0.49	0.44	0.14	-	-	-
Net Income to Common	14.89	14.93	11.27	10.24	6.22	9.13
Net Income Growth	21.19%	32.57%	9.98%	64.63%	-31.82%	-71.06%
Shares Outstanding (Basic)	39	39	39	38	39	39
Shares Outstanding (Diluted)	41	41	41	40	40	41
Shares Change (YoY)	-1.37%	0.05%	1.06%	1.44%	-2.15%	0.38%
EPS (Basic)	0.39	0.38	0.29	0.27	0.16	0.23
EPS (Diluted)	0.37	0.37	0.28	0.25	0.16	0.22
EPS Growth	23.33%	32.14%	12.00%	56.25%	-27.27%	-71.80%
Free Cash Flow	25.92	11.93	1.32	19.12	4.85	2.75
Free Cash Flow Growth	117.24%	805.24%	-93.11%	294.21%	76.30%	-87.53%
Free Cash Flow Per Share	0.64	0.29	0.03	0.47	0.12	0.07
Gross Margin	57.58%	57.52%	59.40%	61.63%	60.99%	62.71%
Operating Margin	8.17%	8.49%	7.98%	7.83%	5.94%	9.89%
Profit Margin	5.37%	5.69%	5.09%	5.60%	4.48%	7.80%
FCF Margin	9.04%	4.41%	0.59%	10.45%	3.49%	2.35%
EBITDA	53.03	51.56	43.27	36.19	23.88	22.89
EBITDA Margin	18.50%	19.08%	19.29%	19.78%	17.20%	19.56%
EBIT	23.4	22.95	17.9	14.33	8.25	11.58
EBIT Margin	8.17%	8.49%	7.98%	7.83%	5.94%	9.89%
Effective Tax Rate	30.40%	29.36%	29.44%	28.82%	30.79%	27.01%

SEC Filings: 10-K · 10-Q